Ask AI
ProCE Banner Series

Conference to Clinic—Advancing Integration of BTK Inhibitors in CLL/SLL Treatment: Expert Insights on Evolving Approaches to Optimize Care

Join us online for this interactive webinar where experts on chronic lymphocytic leukemia (CLL) will discuss optimizing BTK inhibitor–based treatments across lines of therapy based on the latest evidence for patients with CLL including monitoring and managing treatment-associated toxicities.  

  AMA
Who Should Attend

This educational activity is intended for hematologists, medical oncologists, and other healthcare professionals who care for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. 

All Events

Conference to Clinic—Advancing Integration of BTK Inhibitors in CLL/SLL Treatment: Expert Insights on Evolving Approaches to Optimize Care

Upcoming Events

October

23

2025

3:30 PM - 4:30 PM Eastern Time (ET)

Virtual

Topics

Lymphoma

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity's goal is to improve learners' knowledge and competence in treating patients with chronic lymphocytic leukemia / small lymphocytic lymphoma who are receiving or are eligible to receive treatment with BTK inhibitor-based therapy.

Target Audience
This educational activity is intended for hematologists, medical oncologists, and other healthcare professionals who care for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Incorporate CLL/SLL molecular pathogenesis of available BTK inhibitors, as well as mechanisms of resistance and tolerance of prior therapy when developing individualized treatment approaches for patients

  • Select optimal guideline-recommended BTK inhibitor treatments for patients with CLL/SLL across the disease spectrum, based on current evidence, guidelines, expert guidance, and patient goals and preferences 

  • Integrate current evidence on evolving BTK inhibitor approaches into treatment planning for patients with CLL/SLL across the disease spectrum 

  • Identify and manage BTK inhibitor–associated adverse events in patients with CLL/SLL and educate them on when to call their care team

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.com to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191